NERVGEN PHARMA CORP.
NGEN · XNASCIK 1751912fmd_1A2A4ZS10CJN1R2TEGDPMFTBXYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2024 to Dec 31, 2025, 2 periods
| Line item | FY2024 | FY2025 |
|---|---|---|
| Research and development | 16 | 14 |
| Net income | (24) | (44) |